Tablets & Capsules Magazine
Welcome GuestUnited States
Sign In Register

  • Home
  • Tableting
  • Excipients
  • Nutraceutical
  • Manufacturing
  • Capsule Filling
  • Articles
    • Issue Archives
    • Ask An Expert
  • Whitepapers
  • News
  • Webinars
  • Videos
  • Suppliers Guide
  • Product Guide
  • Events

Featured Articles

  • Getting Granular: Supply Chain Issues May Prompt Supplement ‘Finishing’ In-House

    COVID-19 has been a blessing and a curse to many industries. There is no doubt that the current and future outlook for nutraceutical companies manufacturing capsules and tablets will continue to flourish, but what challenges still face this burgeoning market? Globally there is a tendency for manufacturers of finished dose nutraceuticals to rely on excipient providers and other Third Party organizations to granulate various components of their formulations. This over-reliance on outside parties ... read more
  • Switching from Batch to Continuous: Don’t Forget about Formulations

    When pharma companies consider making the switch from batch processing to continuous manufacturing (CM), they often first think about machinery. But they shouldn’t forget about formulation. read more
  • Getting into the Mix: A Q&A on Nutraceuticals

    Nutraceuticals production straddles the interface of food and pharmaceuticals manufacturing—two markets which themselves share plenty of overlap. Pharmaceutical customers often specify higher polish on product contact surfaces as well as exterior finishes that are more aesthetically pleasing. Their control systems often include features for running specific recipes and securely storing batch data. read more
  • You’ve Got Options: Choices Among Punch Heads, Barrels, and Tips—as well as in Die Shapes and Materials—Can Help Fine-Tune Tableting

    The basics of rotary tablet compression tooling have stood the test of time. However, the specifications of tooling design have become more sophisticated. read more

News

  • Chronic Yeast Infection Therapy Trial Produces Positive Outcomes

    June 23, 2022
    Mycovia, a biopharmaceutical company, released topline results from evaluating VIVJOA™ (oteseconazole) capsules in patients suffering from recurrent vulvovaginal candidiasis (RVVC). Also known as ... read more
  • Long-Term Efficacy and Safety Data of Cenobamate Tablets Published

    June 23, 2022
    SK Life Science Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., a pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders, announced that the results ... read more
  • FDA Approves Clorazepate Dipotassium Tablets USP

    June 22, 2022
    ANI Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets. read more
  • Phase II Results of COVID-19 Therapy Published

    June 22, 2022
    Preliminary results of 60 Degrees Pharma’s phase II study of ARAKODA® (tafenoquine) for treatment of mild-moderate COVID-19 disease have been published in the peer-reviewed journal, New Microbes and ... read more
  • FDA Approves Congestive Heart Failure Medicine for Dogs

    June 22, 2022
    Boehringer Ingelheim Animal Health announced that the U.S. Food and Drug Administration Center for Veterinary Medicine (FDA-CVM) has granted conditional approval of VETMEDIN®-CA1 (pimobendan), which ... read more
  • Cremer Introduces Fast, Accurate Counting Machine for Gummies

    June 21, 2022
    Cremer, a supplier of product counting machines in the U.S., has introduced its HQS 1250 Counting & Dispensing Machine, designed specifically for gummy applications in the nutraceutical and ... read more
  • Exelixis Initiates Phase 3 Trial for Metastatic Colorectal Cancer Drug

    June 21, 2022
    Exelixis announced the initiation of STELLAR-303, a phase 3 trial evaluating XL092 in combination with atezolizumab versus regorafenib in patients with metastatic colorectal cancer (CRC) that is not ... read more
  • Apotex Launches Generic Anticoagulant in Canada

    June 21, 2022
    Apotex Inc., a Canadian pharmaceutical manufacturer of generic medicines, announced the launch of APO-ApixabanTM tablets, Canada's first generic alternative to Eliquis®. read more
  • Report: Tablet Coatings Prices Rising 2-5% Over Next Five Years

    June 20, 2022
    Tablet coating prices are projected to rise by 2-5% by 2026, according to a report by SpendEdge. The Tablet Coatings Market is expected to have a CAGR of 4.50% during 2022-2026. read more
Read More News

Current Issue

  • May/June 2022

Product Guide

  • Excipients »
  • Dosage Form Testing Systems »
  • Tablet Presses »
  • Capsule Filling Machines »
  • Powder Filling Equipment »
  • Dissolution Testers »
  • Pharmaceutical Mixers / Blenders »
  • Manufacturing Equipment »
View More Products

Subscriptions

Get started here for your complimentary print or digital subscription
Get started here for your complimentary print or digital subscription
Sign up Now »

Follow Us

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox!
ASK AN EXPERT
tandclogo-aae-module

Have a question about tooling, formulation, equipment, or processing?

Submit Your Question »

Tablets & Capsules

Tablets & Capsules, powered by American Pharmaceutical Review, is the leading publication dedicated to readers who formulate, manufacture, or package solid dosage forms.


A publication of

  • A Site by CompareNetworks
    See our other sites »

Connect with Us

© 2022 CompareNetworks. All rights reserved.

About Tablets & Capsules

  • About Us
  • Contact Us
  • Privacy Policy
  • Disclaimer

Advertise with Us

  • Media Kit Request

Resources

  • Issue Archive
  • Articles
  • News
  • Supplier Guide
  • Product Guide
  • Excipient Search

Subscription

  • Subscribe eNewsletters
  • Subscribe Magazine
  • Manage Your Print Subscription